Distalmotion
- Industry
- Medical Devices
- Founded Year
- 2012
- Headquarters
- Epalinges, Switzerland
- Employee Count
- 130
Key People
- Greg Roche - Chief Executive Officer
- Michael Friedrich - Chief Operating Officer
- Romain Farkas - Chief Technology Officer
- Alex Berthoud - Chief People Officer
- Riccardo Brazerol - Legal Counsel & Board Member
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with significant backgrounds in the medical device industry.
The presence of multiple successful MedTech entrepreneurs in the leadership team enhances the company's strategic direction and operational execution.
- Clinical Need
-
Aspect: Very Strong
Summary: Distalmotion addresses a significant need for accessible and affordable robotic surgical systems.
By offering a hybrid surgical robot that integrates seamlessly into existing procedures, Distalmotion fulfills a pressing clinical need for cost-effective robotic surgery solutions.
- Competition
-
Aspect: Very crowded + Strategics
Summary: The robotic surgery market is highly competitive with established players.
Distalmotion faces competition from well-established companies with significant market share and resources, making market penetration more difficult.
- Technical Challenge
-
Aspect: Complex
Summary: Developing and integrating robotic surgical systems involves significant technical complexities.
The complexity of designing a surgical robot that integrates with existing procedures and meets regulatory standards presents substantial technical challenges.
- Patent
-
Aspect: Strong
Summary: Distalmotion holds strong patents protecting its innovative technologies.
The company's strong patent portfolio safeguards its technological innovations, enhancing its market position and deterring potential competitors.
- Financing
-
Aspect: Well-funded
Summary: The company has secured substantial funding to support its growth and development.
With significant investments from reputable investors, Distalmotion is well-positioned to advance its product development and commercialization efforts.
- Regulatory
-
Aspect: 510k/PMA
Summary: Distalmotion is pursuing necessary regulatory approvals for its products.
Navigating the regulatory landscape is essential for product approval and market access, requiring thorough documentation and compliance with standards.
Opportunity Rollup
- Odds of Success
- 3.1
- Peak Market Share
- 3.7
- Segment CAGR
- 10.7%
- Market Segment
- Medical Devices
- Market Sub Segment
- Robotic Surgical Systems
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.19 |
| 2 | 0.56 |
| 3 | 1.30 |
| 4 | 2.59 |
| 5 | 3.70 |
Key Takeaway
Distalmotion's innovative approach to robotic surgery addresses a significant clinical need, but success will depend on navigating a competitive market and overcoming technical and regulatory challenges.